Adipokines, Inflammation, and Metabolic Diseases
141 ta ish
TYPE 2 DIABETES MELLITUS: GLOBAL EPIDEMIOLOGICAL TRENDS, MOLECULAR MECHANISMS AND RISK FACTORS WITH SPECIAL REFERENCE TO UZBEKISTAN
D.R. Pazliddinova, I.R. Nusratullayev, A.V. Pazliddinov
MaqolaOchiq kirishDiabetes, Cardiovascular Risks, and LipoproteinsZenodo (CERN European Organization for Nuclear Research)20260 iqtibosABIКОМПЛЕКСНАЯ ДИАГНОСТИЧЕСКАЯ РОЛЬ БИОМАРКЕРОВ И РЕТИКУЛОЦИТОВ В ОЦЕНКЕ ЭНДОТЕЛИАЛЬНОЙ ДИСФУНКЦИИ ПРИ САХАРНОМ ДИАБЕТЕ
Фарангиз Садриддиновна Набиева, Гулбадан Завқиддин қизи Бадирдинова
MaqolaOchiq kirishAdipokines, Inflammation, and Metabolic DiseasesZenodo (CERN European Organization for Nuclear Research)20260 iqtibosABIКОМПЛЕКСНАЯ ДИАГНОСТИЧЕСКАЯ РОЛЬ БИОМАРКЕРОВ И РЕТИКУЛОЦИТОВ В ОЦЕНКЕ ЭНДОТЕЛИАЛЬНОЙ ДИСФУНКЦИИ ПРИ САХАРНОМ ДИАБЕТЕ
Фарангиз Садриддиновна Набиева, Гулбадан Завқиддин қизи Бадирдинова
MaqolaAdipokines, Inflammation, and Metabolic DiseasesZenodo (CERN European Organization for Nuclear Research)20260 iqtibosABIImmunometabolic Predictors Of Diabetic Foot Syndrome In Type 2 Diabetes Mellitus
Rakhmonov Nodir Nuritdinovich, Nazirkulov Olimjan Maxmudjonov, Azizova Zukhra Shukhratovna +1
MaqolaOchiq kirishDiabetic Foot Ulcer Assessment and ManagementAmerican Journal Of Social Sciences And Humanity Research20260 iqtibosABIPhysical activity is associated with improved glycemic control but not with IL-6–glycemic interactions in type 2 diabetes: a cross-sectional study
M Ismail, Mutaz Ibrahim Hassan, Amged Gaffer Mostafa +10
MaqolaOchiq kirishAdipokines, Inflammation, and Metabolic DiseasesFrontiers in Endocrinology20260 iqtibosABI